Germany based MAQUET, global market leaders for operating room systems and intensive care units, today announced the launch of its Middle East Office in the Dubai Biotechnology and Research Park (DuBiotech) at a press conference in Dubai.
Held on the first day of Arab Health 2007, the Middle East's largest health fair, the press conference was led by Thomas Schneider, MAQUET Group Director of International Business, Dr. Abdulqader Alkhayat, Executive Director of DuBiotech, and Belal Al-Khatib, Managing Director of MAQUET Middle East.
Thomas Schneider, MAQUET Director of International Business said: "The launch of our regional sales office in DuBiotech emphasises MAQUET's strong commitment to the Middle East region in general and the Gulf states in particular.
We firmly believe that proximity to our customers and business partners will enable us to better understand the needs of the local market".
Dr. Abdulqader Alkhayat, Executive Director of DuBiotech said: "In keeping with the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President and Prime Minister and Ruler of Dubai, DuBiotech is working diligently towards establishing itself as the regional centre of excellence in biotechnology.
It is, therefore, a great honour that MAQUET, a leader in innovation and technological progress in the field of medicine, has chosen Dubai, and specifically DuBiotech, as a base for MAQUET Middle East"
MAQUET Middle East is the German company's 23rd new sales and service subsidiary launched within the last six years alone, representing the impressive growth that MAQUET has witnessed since 2000.
MAQUET, based in Rastatt, Germany, is a global market leader in Medical Systems focused on the Operating Room (OR) and Intensive Care Unit (ICU). Today MAQUET employs 2,800 people worldwide and posted a turnover of more than 550 million in 2005. It currently operates in more than 30 countries, with facilities and sales offices supported by a further 200 distributors and partner companies throughout the world. Its manufacturing centres of excellence are located in Germany, France and Sweden.
"Over the past few years, MAQUET's regional business and sales activities in the Middle East have steadily expanded. With the establishment of our own subsidiary in Dubai, we are expecting a further boost of sales in the region," Belal Al-Khatib, Managing Director of MAQUET Middle East, pointed out.
The Gulf states with Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, the United Arab Emirates and the neighbouring countries Egypt, Iran and Yemen are growth markets with considerable volumes in medical technology.
Exhibiting for the first time ever with its own 168 m stand at Arab Health from 29 January to 1 February 2007, MAQUET Middle East is representing all of its three Business Divisions: MAQUET Critical Care, MAQUET Cardiopulmonary, and MAQUET Surgical Workplaces.
"Dubai's Arab Health Exhibition has become the most important medical and health fair in the area. This is reason enough for us to showcase all our major products," Al-Khatib said.
Among others, MAQUET will present its latest OR table and transportation system MAGNUS, the innovative POWERLED surgical light and the unique MODUTEC / ALPHAPORT ceiling service units. MAQUET Telemedicine provides an interactive installation of a video conferencing system in the operating room.
Furthermore, a critical care set-up to show the MAQUET CRITICAL CARE products will be on display: a SERVO-i ventilator with NAVA (Neurally Adjusted Ventilatory Assist). NAVA is a new approach to mechanical ventilation which allows the patient to control the ventilator with his/her respiratory center. NAVA represents a paradigm shift in the area of ventilation therapy. The complete range of MAQUET CARDIOPULMONARY products for secure open-heart surgery will be on display as well.
MAQUET continues to lead the competition by investing in research and development to provide long-lasting value and define the best medical technology available on the market. The objective of being among the world's leading providers of advanced technology reflects MAQUET's commitment to delivering reliable, innovative, high-quality products and services. Constant investment in research and development for best patient care and treatment in the acute healthcare market is the declared goal of MAQUET.
-Ends-
© Press Release 2007
